Scientific report 2021 of the Chronic Malignancies Working Party (CMWP)
2021 was another year of virtual meetings for the CMWP in the context of the ongoing COVID-19 pandemic. The first scientific and educational meetings took place on Friday 29th and Saturday 30th January. We reviewed and discussed ongoing and planned studies within the six subcommittees: (1) Myelodysplasia including CMML (2) Plasma Cell Diseases (3) Ph. Neg Myeloproliferative Disorders (4) CML/CLL and (6) Practice Harmonisation and Guidelines. The comprehensive educational talks on Saturday consisted of a series of focused sessions on Myelofibrosis by Czerw (Gliwice) and Polverelli (Brescia), Myeloma by Beksac (Ankara) and San Miguel (Navarra), and Myelodysplastic Syndromes by Scheid (Koln) and Platzbecker (Leipzig). Claire Roddie (London) then provided us with a state-of-the-art overview of CAR T-cell therapy in multiple myeloma and Marie Jose Kersten (Amsterdam) spoke on the management of infections in CAR T patients. The final session on CLL was provided by van Gelder (Maastricht) and Gauthier (Seattle).
Our second scientific and educational meeting of 2021 was held in late September and was a great success, thanks to the excellent technical support provided by our colleagues from the EBMT Education and Events Department. This special extended Education event covered a broad range of topics over eight hours of presentations and panel discussions. A highlight was our first session on statistical analysis during which we were provided with comprehensive overviews on Concepts by Iacobelli (Rome) and de Wreede (Leiden), Methods by de Wreede (Leiden) and Data by Gras, Koster and Eikema (All Leiden). Thanks as always are due to our excellent colleagues in Data Management in Leiden without whom none of our studies would be possible.
Principal research studies